Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply
Aliment Pharmacol Ther
.
2017 Apr;45(8):1168.
doi: 10.1111/apt.13998.
Author
A N Ananthakrishnan
1
Affiliation
1
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
PMID:
28326587
PMCID:
PMC5363278
DOI:
10.1111/apt.13998
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Inflammatory Bowel Diseases*
Grants and funding
K23 DK097142/DK/NIDDK NIH HHS/United States
P30 DK043351/DK/NIDDK NIH HHS/United States